CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0005 (-4.35%)
At close: Jul 17, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1114606054
Market Cap Growth
-83.90%-90.25%-75.95%-0.25%11.27%-
Enterprise Value
7.557.7115.92145.8382.98240.86
Last Close Price
0.010.07120.0022000.0020540.0019820.00
PB Ratio
-0.06-0.26-7.65-1.43-5.62-7.08
Debt / Equity Ratio
-0.010-0.37-0.063.970.05
Net Debt / Equity Ratio
0.030.180.93-0.03-0.87-1.05
Net Debt / EBITDA Ratio
0.010.050.11-0.19-1.60-
Net Debt / FCF Ratio
-0.060.14-0.23-8.54-
Quick Ratio
0.080.180.450.460.0211.20
Current Ratio
0.140.300.500.561.3813.88
Return on Equity (ROE)
281.54%542.71%41.65%41.05%-0.77%0.00%
Return on Assets (ROA)
-628.04%-374.96%-285.85%-32.32%40.42%0.00%
Return on Invested Capital (ROIC)
---7646.16%-114.45%47.16%0.00%
Return on Capital Employed (ROCE)
252.03%555.96%-7646.14%-115.96%-6.07%0.00%
Buyback Yield / Dilution
-19215.02%-14499.99%-9825.18%97.38%-306.16%-17.14%
Total Shareholder Return
-19215.02%-14499.99%-9825.18%97.38%-306.16%-17.14%